Advertisement

Central European Journal of Medicine

, Volume 8, Issue 4, pp 499–502 | Cite as

Progressive course of isolated splenic myeloid sarcoma

  • Darko Antic
  • Maja Perunicic Jovanovic
  • Djordje Knezevic
  • Slavenko Ostojic
  • Ivo Elezovic
Research Article

Abstract

A previously healthy 40-year-old male presented with a 2-week history of fever and abdominal discomfort that was resistant to empirical broad-spectrum antibiotic treatment. The patient’s blood cell count and complete biochemical panel was normal, except for an increased lactate dehydrogenase level. Ultrasonography and computed tomography of the abdomen showed a large, soft tissue mass had infiltrated superior part of the spleen. Splenectomy with total tumor mass removal were performed. The pathological examination of the tumor tissue confirmed diagnosis of isolated myeloid sarcoma with monoblastic differentiation. Despite intensive antileukemic therapy, patient died four months after diagnosis was established.

Keywords

Spleen Isolated myeloid sarcoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Pileri SA, Orayi A, Falini B: Myeloid sarcoma. In Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoetic and lymphoid tissues. Lyon, IARC, 2008, pp 140–141Google Scholar
  2. [2]
    Burns A. Observation of surgical anatomy, head and neck. Edinburgh: Thomas Royce and co;1811, pp 364–366Google Scholar
  3. [3]
    King A. A case of chloroma. Monthly J med 1853;17:97Google Scholar
  4. [4]
    Rappaport H. Tumors of the hematopoetic system. Armed Forces Inst Pathol 1966; 241–243Google Scholar
  5. [5]
    Hutchinson RE, Kurec AS, Davey FR. Granulocytic sarcoma. Clin Lab Med. 1990; 10; 889–901Google Scholar
  6. [6]
    Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma. 2006; 47(12)Google Scholar
  7. [7]
    Antic D, Verstovsek S, Elezovic I, Grujicic D, Gotic M, Bila J et al. Spinal epidural granulocytic sarcoma in non-leukemic patient. Int J Hematol. 2009 Jan;89(1):95–97PubMedCrossRefGoogle Scholar
  8. [8]
    Antic D, Elezovic I, Bogdanovic A, Vukovic NS, Pavlovic A, Jovanovic MP Isolated myeloid sarcoma of the gastrointestinal tract. Intern Med. 2010;49(9):853–856PubMedCrossRefGoogle Scholar
  9. [9]
    Audouin J, Comperat E, Le Tourneau A, Camilleri-Broët S, Adida C, Molina T et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis Int J Surg Pathol. 2003; 11(4):271–282PubMedCrossRefGoogle Scholar
  10. [10]
    Alexiev BA, Wang W, Ning Y, Chumsri S, Gojo I, Rodgers WH et al. Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study. Diagn Pathol. 2007; 2:42PubMedCrossRefGoogle Scholar
  11. [11]
    Klco JM, Welch JS, Nguyen TT, Hurley MY, Kreisel FH, Hassan A et al. State of the art in myeloid sarcoma. Int J Lab Hematol. 2011;33(6):555–565PubMedCrossRefGoogle Scholar
  12. [12]
    Breccia M, Mandelli F, Petti MC, D’Andrea M, Pescarmona E, Pileri SA et al. Clinicopathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res. 2004; 28(11):1165–1169PubMedCrossRefGoogle Scholar
  13. [13]
    Rund D, Azar I, Shperling O. A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease. Adv Exp Med Biol. 1999;457:71–75PubMedCrossRefGoogle Scholar
  14. [14]
    Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118(14):3785–3793PubMedCrossRefGoogle Scholar
  15. [15]
    Meis JM, Butler JJ, Osborne BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer. 1986; 58(12):2697–2709PubMedCrossRefGoogle Scholar
  16. [16]
    Byrd, J.C., Edenfield, W.J., Shields, D.J. and Dawson, N.A. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: A Clinical Review J. Clin. Oncol. 1995; 13(7), 1800–1816PubMedGoogle Scholar
  17. [17]
    Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsed cases. Cancer 1981;48: 1426–1437PubMedCrossRefGoogle Scholar
  18. [18]
    Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002; 94(6):1739–1746PubMedCrossRefGoogle Scholar
  19. [19]
    Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O’Brien S, Brandt M et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008; 113(6):1370–1378PubMedCrossRefGoogle Scholar
  20. [20]
    Pileri SA Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al. Myeloid sarcoma: clinico pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007; 21(2):340–350PubMedCrossRefGoogle Scholar
  21. [21]
    Lan TY, Lin DT, Tien HF, Yang RS, Chen CY, Wu K. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol. 2009;122(4):238–246PubMedCrossRefGoogle Scholar
  22. [22]
    Antic D, Elezovic I, Milic N, Suvajdzic N, Vidovic A, Perunicic M et al. Is there a “gold” standard treatment for patients with isolated myeloid sarcoma? Biomed Pharmacother. 2013;67(1):72–77PubMedCrossRefGoogle Scholar
  23. [23]
    Chevallier P, Labopin M, Cornelissen J, Socié G, Rocha V, Mohty M; ALWP of EBMT. Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation. Haematologica.2011;96(9):1391–1394PubMedCrossRefGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Darko Antic
    • 1
    • 3
  • Maja Perunicic Jovanovic
    • 1
  • Djordje Knezevic
    • 2
  • Slavenko Ostojic
    • 2
    • 3
  • Ivo Elezovic
    • 1
    • 3
  1. 1.Clinic for HematologyClinical Center SerbiaBelgradeSerbia
  2. 2.Clinic for Digestive SurgeryClinical Center SerbiaBelgradeSerbia
  3. 3.Medical FacultyUniversity BelgradeBelgradeSerbia

Personalised recommendations